The epilepsy surgery market size is estimated to be USD 1050.75 million in 2022 and is expected to witness a CAGR of 7.64% during the forecast period 2023-2033. The increasing number of incidents of brain damage brought on by traffic collisions, robotic surgery advancement and adoption, rising incidence of epilepsy and need for surgery are projected to drive the market growth in near future. However, strict regulatory restrictions and surgical difficulties are predicted to limit market growth are expected to restrain the market growth.

Segmentation

By Procedure Type

On the basis of procedure type, the market is segregated into laser interstitial thermal therapy (LITT), resective surgery, and others. In 2022, the resective surgery segment held the highest market share owing to increasing tumors, brain injury, and malformation

By End User

On the basis of end user, the market is categorized into specialty centers, hospitals & clinics, and others. In 2022, the hospitals & clinics segment held the highest market share owing to growing number of patients receiving epilepsy diagnoses and having epilepsy surgery.

Regional Markets

In 2022, North America region accounted for the highest revenue in the epilepsy surgery market and is expected to maintain its dominance during the forecast period. This is attributed to rising prevalence of epilepsy, accessibility of reputable medical facilities, and widespread occurrence of neurological conditions. However, the Asia-Pacific region is predicted to grow at the fastest rate during the projection period owing to efforts by the government to enhance the healthcare industry, increasing prevalence of a sizable elderly population, and rise in the prevalence of epilepsy in the area.

Competitor Insights

Some of the key players operating in the epilepsy surgery market are Auris Health, Inc. (Hansen Medical, Inc.) (US), Cephalon, Inc. (US), CMR Surgical (UK), Intuitive Surgical (US), Livanova Plc (UK), Medtronic Plc (Mazor Robotics) (Ireland), Monteris Medical (US), Natus Medical Incorporated (US), Stryker (US), and Zimmer Biomet Holdings Inc. (US).

This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including product and end user from 2023 to 2033.

Report Scope:

Segmentation: Epilepsy Surgery Market Report 2022 – 2033

Procedure Type (Revenue, USD Million), 2022 – 2033

• Laser Interstitial Thermal Therapy (LITT)
• Resective Surgery
• Others

End User (Revenue, USD Million), 2022 – 2033

• Specialty Centers
• Hospitals & Clinics
• Others

By Region (Revenue, USD Million), 2022 – 2033

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • Rest of MEA